| Net Loss per Share |
12.Net Loss per Share
Diluted loss per share is the same as basic loss per share for all periods presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss. The following securities have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive:
|
|
|
Three and Nine Months Ended September 30,
|
|
|
|
|
2013
|
|
2014
|
|
|
Redeemable convertible preferred stock:
|
|
|
|
|
|
|
Series A
|
|
10,033,976
|
|
—
|
|
|
Series B
|
|
5,057,901
|
|
—
|
|
|
Series C
|
|
4,429,601
|
|
—
|
|
|
Series D
|
|
3,979,730
|
|
—
|
|
|
Warrants to purchase Series D redeemable convertible preferred stock
|
|
12,797
|
|
—
|
|
|
Stock options
|
|
5,483,948
|
|
6,282,657
|
|
|
Restricted stock units
|
|
—
|
|
1,013,239
|
|
Basic and diluted net loss per share attributable to common stockholders is calculated as follows:
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
|
|
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
|
Numerator (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders
|
|
$
|
(10,220
|
)
|
$
|
(7,337
|
)
|
$
|
(23,035
|
)
|
$
|
(25,071
|
)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding, basic and diluted
|
|
7,415,777
|
|
40,269,937
|
|
7,401,842
|
|
29,209,970
|
|
|
Net loss per share attributable to common stockholders, basic and diluted
|
|
$
|
(1.38
|
)
|
$
|
(0.18
|
)
|
$
|
(3.11
|
)
|
$
|
(0.86
|
)
|
|